SYSTEMIC ADVERSE DRUG REACTIONS OF ANTIHYPERTENSIVE AGENTS

Author(s)

Subedi N
College of Medical Sciences, Chitwan, Nepal

OBJECTIVES:

Achieving blood pressure goals usually requires two or more antihypertensive agents (AHAs); however; increasing the number of AHAs in a regimen may lead to even more adverse drug reactions (ADRs). The objective of the study is to describe the common systems involved in adverse drug reactions associated with antihypertensive therapy and categorise them according to Naranjo algorithm.  METHODS: We studied 382 adult (18 years or older) hypertensive patients on anti-hypertensive treatment at department of Cardiology at a tertiary referral center in Central Nepal from July to September 2014. Naranjo algorithm was used to categorise the causality relationship into possible, probable, definite and doubtful. RESULTS: : Out of 382 patients in the study period, 140 (36.65%) were receiving monotherapy and 242 (63.35%) multiple drug therapy. Among the total 67 (17.54%) ADR cases reported, Calcium channel blockers contributed to 22 (32.84%) ADRs followed by Angiotensin converting enzyme inhibitors in 17 (25.38%), Angiotensin receptor blockers (13 or 19.4%), diuretic (9 or 13.44%) and Beta adrenergic antagonists to (6 or 8.95%) cases. Cardiovascular system (40 or 59.70%) was the most affected followed by Central Nervous System (16 or 23.88%) and Respiratory and dermatological system each in 11 (16.42%) cases. Only nine (13.4%) ADRs were definite, 16 (23.9%) probable, 39 (58.2%) possible and three (4.5%) cases were categorized as doubtful as per Naranjo algorithm.  CONCLUSIONS: Cardiovascular system was the most common system affected by the ADR of antihypertensive agents and only a few could be categorised as definite ADRs based on Naranjo algorithm. ADR monitoring needs to be done in hospital settings continuously so that untoward effect caused by antihypertensive agents can be identified and documented.

Conference/Value in Health Info

2016-09, ISPOR Asia Pacific 2016, Singapore

Value in Health, Vol. 19, No. 7 (November 2016)

Code

PCV1

Topic

Epidemiology & Public Health

Topic Subcategory

Safety & Pharmacoepidemiology

Disease

Cardiovascular Disorders

Explore Related HEOR by Topic


Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×